| Jeffrey Zavala, MD | |
|
1233 N 30th St, Billings, MT 59101-0127 | |
| (406) 237-3065 | |
| Not Available |
| Full Name | Jeffrey Zavala |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 1233 N 30th St, Billings, Montana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477596609 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 7143502-1205 (Utah) | Secondary |
| 207Q00000X | Family Medicine | 6912 (Montana) | Primary |
| Entity Name | Scl Health Montana |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083655997 PECOS PAC ID: 3476457714 Enrollment ID: O20031229000380 |
News Archive
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Researchers at UC Irvine have found that a new compound not only relieves the cognitive symptoms of Alzheimer's disease, but also reduces the two types of brain lesions that are hallmarks of this devastating disease, thereby blocking its progression.
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.
A Rochester Institute of Technology researcher is part of a team that has been awarded a National Science Foundation grant to use artificial intelligence to better understand the role of facial expressions in signed and spoken languages.
› Verified 4 days ago
| Entity Name | Scl Health Medical Group - Billings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508289703 PECOS PAC ID: 9638491574 Enrollment ID: O20141204001495 |
News Archive
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Researchers at UC Irvine have found that a new compound not only relieves the cognitive symptoms of Alzheimer's disease, but also reduces the two types of brain lesions that are hallmarks of this devastating disease, thereby blocking its progression.
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.
A Rochester Institute of Technology researcher is part of a team that has been awarded a National Science Foundation grant to use artificial intelligence to better understand the role of facial expressions in signed and spoken languages.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Zavala, MD 1233 N 30th St, Billings, MT 59101-0127 Ph: (406) 237-3065 | Jeffrey Zavala, MD 1233 N 30th St, Billings, MT 59101-0127 Ph: (406) 237-3065 |
News Archive
BioAlliance Pharma SA, a company dedicated to the supportive care and treatment of cancer patients, presented preclinical and promising preliminary phase I clinical results with its AMEP biotherapy at the "Electrochemotherapy 1st International Users' Meeting"(Bologna, Italy, November 19-20, 2010).
Researchers at UC Irvine have found that a new compound not only relieves the cognitive symptoms of Alzheimer's disease, but also reduces the two types of brain lesions that are hallmarks of this devastating disease, thereby blocking its progression.
Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.
A Rochester Institute of Technology researcher is part of a team that has been awarded a National Science Foundation grant to use artificial intelligence to better understand the role of facial expressions in signed and spoken languages.
› Verified 4 days ago
Michael D. Monday, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1775 Spring Creek Dr, Billings, MT 59102 Phone: 406-373-3500 Fax: 406-373-3520 | |
Aaron James Audet, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Angel M. Eads, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3220 Fax: 406-651-6406 | |
John Konow, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Cynthia Kay Brewer, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 801 N 29th St, Billings, MT 59101 Phone: 406-238-2500 | |
Dr. Amy Solomon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 Fax: 406-247-3389 | |
Lawrence A. Hemmer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2675 Central Ave, Billings, MT 59102 Phone: 406-238-2500 |